Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

BACKGROUND: The advent of anti-tumor necrosis factor-α (TNFα) drugs has changed the course of ankylosing spondylitis (AS). While data are available concerning the long term effectiveness of single anti-TNF agents, little has been published about predictors of treatment response in AS. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzin, Mariagrazia, Ortolan, Augusta, Frallonardo, Paola, Oliviero, Francesca, Punzi, Leonardo, Ramonda, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513706/
https://www.ncbi.nlm.nih.gov/pubmed/26205000
http://dx.doi.org/10.1186/s12891-015-0620-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513706/
https://www.ncbi.nlm.nih.gov/pubmed/26205000
http://dx.doi.org/10.1186/s12891-015-0620-4

Ejemplares similares